TFF Pharmaceuticals, Inc. — Form D
TFF Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-03-27. The offering totals $14.2M, of which $14.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-03-27
- Form: D
- Accession: 0001733413-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $14.2M
- Amount sold: $14.2M
- Minimum investment: $10K
- Investors: 224
- Date of first sale: 2018-03-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-308663
Issuer
- Name: TFF Pharmaceuticals, Inc.
- CIK: 0001733413
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 1751 RIVER RUN, FORT WORTH, TX, 76107
- Phone: 817-438-6168
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| ROBERT S MILLS, JR. | Executive Officer | FORT WORTH, TX |
| BRANDI S ROBERTS | Director | FORT WORTH, TX |
| THOMAS S KING | Director | FORT WORTH, TX |
| ROBERT S MILLS, JR. | Director | FORT WORTH, TX |
| STEPHEN S ROCAMBOLI | Director | FORT WORTH, TX |
| HARLAN S WEISMAN | Director | FORT WORTH, TX |
| HARLAN S WEISMAN | Executive Officer | FORT WORTH, TX |
| ZAMANEH S MIKHAK | Executive Officer | FORT WORTH, TX |
| KIRK S COLEMAN | Executive Officer | FORT WORTH, TX |
| MICHAEL S PATANE | Director | FORT WORTH, TX |
| CATHERINE S LEE | Director | FORT WORTH, TX |
| RANDY S THURMAN | Director | AUSTIN, TX |
| MALCOLM S FAIRBAIRN | Director | AUSTIN, TX |
| BRIAN S WINDSOR | Director | AUSTIN, TX |
| BRIAN S WINDSOR | Executive Officer | AUSTIN, TX |
| AARON S FLETCHER | Director | AUSTIN, TX |
| GLENN S MATTES | Director | AUSTIN, TX |
| GLENN S MATTES | Executive Officer | AUSTIN, TX |
Other filings by this issuer (3)
More